Trial Profile
Double-blind, Randomized, Vehicle-controlled, Multicenter, Multinational, Parallel-group Study of the Efficacy and Safety of Mapracorat Ointment in Three Concentrations Over Max. 4 Weeks in Subjects With Atopic Dermatitis (AD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jan 2015
Price :
$35
*
At a glance
- Drugs Mapracorat (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Bayer
- 23 Dec 2014 New trial record